Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrazione
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INVIVO THERAPEUTICS HOLDINGS CORP.

(NVIV)
  Rapporto
Tempo differito Nasdaq  -  21:59 29/09/2022
4.250 USD   +3.66%
08/08InVivo Therapeutics Holdings Corp. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 giugno 2022
CI
13/07Invivo Therapeutics Holdings Corp. annuncia la nomina di Heather M. Hamel a Chief Legal Officer e Consigliere Generale
CI
02/06InVivo Therapeutics completa l'arruolamento nello studio sulla lesione midollare acuta
MT
RiassuntoQuotazioniGraficiNotizieCalendarioSocietąFinanzaDerivatiFondi 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su INVIVO THERAPEUTICS HOLDINGS CORP.
13/09Invivo Therapeutics: Modification to Rights of Security Holders - Form 8-K
13/09Invivo Therapeutics Holdings Corp.: Material Modification to Rights of Security Holders, ..
12/09InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Glo..
09/09InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Glo..
08/08INVIVO THERAPEUTICS HOLDINGS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
08/08InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter and ..
04/08Top Premarket Gainers
13/07InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer an..
13/07Invivo Therapeutics Holdings Corp. Announces Appointment of Heather M. Hamel as Chief L..
12/07Invivo Therapeutics Holdings Corp.: Change in Directors or Principal Officers, Financial ..
08/06InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Stud..
02/06InVivo Therapeutics Completes Enrollment in Acute Spinal Cord Injury Study
02/06Invivo Therapeutics: Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal ..
02/06Invivo Therapeutics Holdings Corp.: Other Events, Financial Statements and Exhibits (form..
02/06InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal..
02/06InVivo Therapeutics Holdings Corp. Announces Completion of Enrollment for the INSPIRE 2..
26/05Invivo Therapeutics Holdings Corp.: Material Modification to Rights of Security Holders, ..
13/05Invivo Therapeutics Holdings Corp.: Other Events (form 8-K)
11/05Invivo: Q1 Earnings Snapshot
10/05INVIVO THERAPEUTICS HOLDINGS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
10/05InVivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended..
26/04Invivo Therapeutics Holdings Corp.: Material Modification to Rights of Security Holders, ..
18/04Top Premarket Decliners
14/04Invivo Therapeutics Holdings Corp.: Other Events (form 8-K)
14/04InVivo Therapeutics Announces Reverse Stock Split
07/03INVIVO THERAPEUTICS HOLDINGS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
07/03InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Full Year Ended Dec..
07/03North American Morning Briefing: Stocks to Fall, -3-
06/01InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conf..
2021Invivo Therapeutics Holdings Corp.: Entry into a Material Definitive Agreement, Financial..
2021Invivo Therapeutics Holdings Corp.: Notice of Delisting or Failure to Satisfy a Continued..
2021Invivo: Q3 Earnings Snapshot
2021INVIVO THERAPEUTICS HOLDINGS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
2021InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter and N..
2021Invivo Therapeutics: Announces Participation at Upcoming H.C. Wainwright Annual Global In..
2021InVivo Therapeutics : Reaches 75% of Enrollment Target for Spinal Co..
2021Invivo Therapeutics: Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal ..
2021InVivo Therapeutics Holdings Corp. Achieves 75% Target Enrollment for INSPIRE 2.0 Spina..
2021Top Premarket Gainers
2021Invivo Therapeutics: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
2021Invivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter Ende..
2021Invivo Therapeutics Holdings Corp.: Change in Directors or Principal Officers, Submission..
2021InVivo Therapeutics : Preclinical Module for Humanitarian Device Exe..
2021Invivo Therapeutics: Announces FDA Acceptance of Preclinical Module in Support of Company..
2021Invivo Therapeutics Holdings Corp. Announces FDA Acceptance of Preclinical Module in Su..
2021InVivo Therapeutics Up After FDA Accepts Preclinical Part of Application
2021Invivo Therapeutics: Urges All Stockholders to Vote at the 2021 Annual Meeting to Be Held..
2021Invivo Therapeutics: LEASE AGREEMENT (Form 8-K)
2021Invivo Therapeutics Holdings Corp.: Entry into a Material Definitive Agreement, Terminati..
2021Invivo Therapeutics: Delisting/Transfer of Listing (Form 8-K)
2021Invivo Therapeutics Holdings Corp.: Notice of Delisting or Failure to Satisfy a Continued..
2021Invivo Therapeutics: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
2021Invivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended..
2021Invivo Therapeutics: Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC In..
2021Invivo Therapeutics: Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life ..
2021Invivo Therapeutics: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
2021Invivo Therapeutics Holdings Corp. Reports Earnings Results for the Full Year Ended Dec..
2021Invivo Therapeutics: Announces Publication in Peer-Reviewed Journal of Neurosurgery, Spin..
2021Invivo Therapeutics Announces Public: Spine
2021InVivo Therapeutics Holdings Corp. Announces Public..
2021Invivo Therapeutics Holdings Corp.: Other Events (form 8-K)
2021Certain Options of InVivo Therapeutics Holdings Corp. are subject to a Lock-Up Agreemen..
2021Certain Warrants of InVivo Therapeutics Holdings Corp. are subject to a Lock-Up Agreeme..
2021Certain Common Stock of InVivo Therapeutics Holdings Corp. are subject to a Lock-Up Agr..
2020Invivo Therapeutics Holdings Corp.: Notice of Delisting or Failure to Satisfy a Continued..
2020Invivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter Ended..
2020Invivo Therapeutics: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
2020Invivo Therapeutics: Announces Closing of $15.0 Million Public Offering
2020Invivo Therapeutics: Announces Closing of $15.0 Million Public Offering
2020Invivo Therapeutics Holdings Corp.: Other Events, Financial Statements and Exhibits (form..
2020Invivo Therapeutics: Announces Pricing of $15.0 Million Public Offering
2020Invivo Therapeutics: Announces Pricing of $15.0 Million Public Offering
2020Invivo Therapeutics: Announces Presentation at the Upcoming H.C Wainwright Virtual Global..
2020Invivo Therapeutics: Announces Presentation at the Upcoming H.C Wainwright Virtual Global..
2020Invivo Therapeutics: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
2020Invivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter Ende..
2020Invivo Therapeutics Holdings Corp.: Change in Directors or Principal Officers, Amendments..
2020Certain Common Stock of InVivo Therapeutics Holdings Corp. are subject to a Lock-Up Agr..
2020Certain Warrants of InVivo Therapeutics Holdings Corp. are subject to a Lock-Up Agreeme..
2020Certain Options of InVivo Therapeutics Holdings Corp. are subject to a Lock-Up Agreemen..
2020Certain Restricted Stock Units of InVivo Therapeutics Holdings Corp. are subject to a L..
2020Invivo Therapeutics Holdings Corp.: Amendments to Articles of Inc. or Bylaws; Change in F..
2020Invivo: 1Q Earnings Snapshot
2020Invivo Therapeutics: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
2020Invivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended..
2020Invivo Therapeutics: Announces Closing of $3.0 Million Registered Direct Offering Priced ..
2020Invivo Therapeutics: Announces Closing of $3.0 Million Registered Direct Offering Priced ..
2020Invivo Therapeutics Holdings Corp.: Entry into a Material Definitive Agreement, Unregiste..
2020Invivo Therapeutics: Announces $3.0 Million Registered Direct Offering Priced At-the-Mark..
2020Invivo Therapeutics: Announces Closing of $7.0 Million Public Offering
2020Invivo Therapeutics Holdings Corp.: Other Events, Financial Statements and Exhibits (form..
2020Invivo Therapeutics: SEC Filing (424B4)
2020Invivo Therapeutics: Announces Pricing of $7.0 Million Public Offering
2020Invivo Therapeutics Holdings Corp.: Other Events (form 8-K)
2020Invivo Therapeutics: Submission of Matters to a Vote of Security Holders (form 8-K/A)
2020Invivo Therapeutics: SEC Filing - S-1
2020Invivo Therapeutics: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
2020Invivo Therapeutics Holdings Corp. Reports Earnings Results for the Full Year Ended Dec..
2020InVivo Therapeutics Holdings Corp. Auditor Raises 'Going Concern' Doubt
2020Invivo Therapeutics Holdings Corp.: Material Modification to Rights of Security Holders, ..